Literature DB >> 478798

Radiologic assessment of pulmonary arterial pressure and blood volume in chronic, diffuse, interstitial pulmonary diseases.

J H Austin, B G Yount, H M Thomas, Y Enson.   

Abstract

Chronic, diffuse, interstitial pulmonary diseases may cause an increase in mean pulmonary arterial pressure (PAP) and a decrease in pulmonary blood volume (PBV). We compared 12 cardiovascular and three parenchymal assessments on plain chest radiographs with values of PAP and PBV obtained during cardiac catheterization in 29 patients with such diseases (progressive systemic sclerosis 20, sarcoidosis six, miscellaneous three) and normal pulmonary venous pressures. PAP ranged from 10 to 40 torr (mean 19, SD +/- 7), PBV from 6.4 to 10.8% of total blood volume (mean 8.4, SD +/- 1.2). PBV was significantly related to eight radiologic variables. PAP was significantly related to the severity of parenchymal disease and size of the central pulmonary arteries, both of which were assessed radiologically. Diversion of blood flow to upper zones was significantly related to restriction of the pulmonary vascular bed, but was not necessarily a sign of increased PAP. In general, pulmonary hemodynamic abnormalities appeared proportional to the radiologic severity of parenchymal disease.

Entities:  

Mesh:

Year:  1979        PMID: 478798     DOI: 10.1097/00004424-197901000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

1.  Estimation of pulmonary arterial pressure by measuring the size of the right pulmonary artery in the suprasternal echocardiogram.

Authors:  W Kasper; T Meinertz
Journal:  Klin Wochenschr       Date:  1982-01-15

2.  Chest radiographic data acquisition and quality assurance in multicenter studies.

Authors:  R H Cleveland; M Schluchter; B P Wood; W E Berdon; M I Boechat; K A Easley; M Meziane; R B Mellins; K I Norton; E Singleton; L Trautwein
Journal:  Pediatr Radiol       Date:  1997-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.